New England Biolabs (NEB) is at the forefront of biotechnology research, with a focus on providing high-quality products and innovative solutions for researchers worldwide. Recently, Sales Manager of Australia & New Zealand, Jenny Brown, sat down with Timothy Mercer, Professor at the University of Queensland and Director of the BASE facility, along with Seth Cheetham, Associate Professor at the University of Queensland and Deputy Director of the BASE facility. Together, they discussed a groundbreaking protocol for mRNA synthesis published in Nature Protocols, showcasing NEB’s commitment to advancing scientific discovery. NEB is known for its top-notch DNase I products, essential for various applications such as genetic material purification and sample preparation for advanced sequencing technologies. Their collaboration with Twist Bioscience on the TWIST Human Methylation Panel has revolutionized high-throughput methylation sequencing solutions, making it a widely adopted tool in genomic research. In addition, the recent launch of the NEBNext® Low-bias Small RNA Library Prep Kit introduces a novel approach to capturing the true diversity of RNA samples, further solidifying NEB’s reputation for innovation in the biotech industry. Dr. Sinha, a distinguished research scientist at NEB, has been instrumental in driving advancements in genomics and parasitology since joining the organization in 2017. NEB’s partnership with the ISS National Laboratory has led to groundbreaking research initiatives, including the exploration of DNA repair and immune dysfunction in space, showcasing their dedication to pushing the boundaries of scientific exploration. Stay tuned for more exciting developments from New England Biolabs as they continue to shape the future of biotechnology.
Tags: None
Read more from search.yahoo.com